The role of radiotherapy in immunotherapy strategies in the central nervous system
- PMID: 38437664
- PMCID: PMC10911795
- DOI: 10.1093/neuonc/noad184
The role of radiotherapy in immunotherapy strategies in the central nervous system
Abstract
The clinical efficacy and relative tolerability of adverse effects of immune checkpoint immunotherapy have led to its increasingly routine use in the management of multiple advanced solid malignancies. Radiation therapy (RT) is well-known to have both local and distant immunomodulatory effects, which has led to extensive investigation into the synergism of these 2 therapies. While the central nervous system (CNS) has historically been thought to be a sanctuary site, well-protected by the blood-brain barrier from the effects of immunotherapy, over the last several years studies have shown the benefits of these drugs, particularly in metastatic disease involving the CNS. This review explores current progress and the future of combination therapy with immune checkpoint inhibitors and RT.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
T.J.C.W. reports personal fees and nonfinancial support from AbbVie, personal fees from Cancer Panels, personal fees from Doximity, personal fees and nonfinancial support from Elekta, personal fees and nonfinancial support from Merck, personal fees and nonfinancial support from Novocure, personal fees and nonfinancial support from RTOG Foundation, personal fees from Rutgers, personal fees from the University of Iowa, personal fees from Wolters Kluwer, grants and nonfinancial support from Genentech, grants and nonfinancial support from Varian, personal fees from Iylon Precision Oncology, outside the submitted work. M.T.M. reports royalties from Wolters Kluwer outside the submitted work. M.D.C. reports consulting for Monteris, Inc. and is on the Data Safety Monitoring Board for Biomimetix. All other authors have no relevant conflicts of interest to disclose.
Similar articles
-
Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.Adv Exp Med Biol. 2023;1394:73-84. doi: 10.1007/978-3-031-14732-6_5. Adv Exp Med Biol. 2023. PMID: 36587382
-
Immunothérapie des glioblastomes.Bull Cancer. 2018 Dec;105 Suppl 1:S59-S67. doi: 10.1016/S0007-4551(18)30391-6. Bull Cancer. 2018. PMID: 30595200 Review. French.
-
Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies.Front Oncol. 2016 Oct 7;6:212. doi: 10.3389/fonc.2016.00212. eCollection 2016. Front Oncol. 2016. PMID: 27774435 Free PMC article. Review.
-
Narrative review of immune checkpoint inhibitors and radiation therapy for brain metastases.Transl Cancer Res. 2021 May;10(5):2527-2536. doi: 10.21037/tcr-20-3027. Transl Cancer Res. 2021. PMID: 35116569 Free PMC article. Review.
-
Advances in Radiotherapy Immune Modulation: From Bench-to-Bedside and Back Again.Surg Oncol Clin N Am. 2023 Jul;32(3):617-629. doi: 10.1016/j.soc.2023.02.009. Epub 2023 Apr 4. Surg Oncol Clin N Am. 2023. PMID: 37182996 Review.
References
-
- Ruckert M, Flohr AS, Hecht M, Gaipl US.. Radiotherapy and the immune system: more than just immune suppression. Stem Cells. 2021;39(9):1155–1165. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources